For the period from 1 January 2023 to 31 December 2023 | |||
1 Jan 2023 | 1 Jan 2022 | ||
to | to | ||
31 Dec 2023 | 31 Dec 2022 | ||
Income | Note | GBP | GBP |
Bank interest earned | |||
Expenses | |||
Operating expenses | 5 | ||
Share-based payment expenses | 5 | ||
Unrealised loss on revaluation of warrants and redeemable shares | |||
Realised loss on revaluation of warrants and redeemable shares | |||
Unrealised loss on foreign exchange | |||
Realised loss on foreign exchange | |||
Interest expense on financial liabilities measured at amortised cost | |||
Net loss before taxation | ( | ( | |
Tax | 7 | ( | |
Loss for the year | ( | ( | |
Other comprehensive income | |||
Exchange difference on translation of foreign operations | ( | ||
Total comprehensive loss for the year | ( | ( | |
Basic and diluted earnings per share | 19 | ( | ( |
The above results are in respect of continuing operations of the Company. | |||
The notes on pages 37 - 59 form an integral part of these financial statements. | 33 |
31 Dec 2023 | 31 Dec 2022 | ||
Note | GBP | GBP | |
Assets | |||
Non-current assets | |||
Intangible Assets | 8 | ||
Property, plant and equipment | 9 | ||
Total Non-current assets | |||
Current assets | |||
Cash and cash equivalents | 10 | ||
Trade and other receivables | 11 | ||
Total Current assets | |||
TOTAL ASSETS | |||
Liabilities | |||
Current liabilities | |||
Trade and other payables | 12 | ( | ( |
Loans and borrowings | 13 | ( | ( |
Provisions | ( | ||
Total Current liabilities | ( | ( | |
Non-current liabilities | |||
Warrants | 15 | ( | |
Loans and borrowings | 13 | ( | ( |
Total Non-current liabilities | ( | ( | |
Net assets | ( | ( | |
Equity | |||
Issued share capital and share premium | 14 | ||
Retained earnings | ( | ( | |
Capital contribution | |||
Foreign currency translation reserve | |||
Share-based payment reserve | |||
Total equity | ( | ( |
1 Jan 2023 | 1 Jan 2022 | ||
to | to | ||
31 Dec 2023 | 31 Dec 2022 | ||
Operating activities | Note | GBP | GBP |
Net loss for the year | ( | ( | |
Items not affecting cash: | |||
Increase in trade and other receivables | ( | ||
(Decrease)/Increase in trade and other payables | |||
Interest expense on financial liabilities measured at amortised cost | |||
Realised loss on revaluation of warrants and redeemable shares | |||
Unrealised loss on revaluation of warrants and redeemable shares | |||
Depreciation of property, plant and equipment | |||
Amortisation and impairment of intangible assets | |||
Non-cash settlement of payables | |||
Foreign exchange movements | |||
Finance costs | |||
Guarantee provision | |||
Share-based payment expense | |||
Listing expense | |||
Bank interest earned | ( | ||
Net cash flows used in operating activities | ( | ( | |
Investing activities | |||
Interest earned | |||
Cash acquired on business combination | |||
Net cash flows used in investing activities | |||
Financing activities | 22 | ||
Cash inflow loans short-term | |||
Shares Issued/(Redeemed) | |||
Net cash flows used in financing activities | |||
Change in cash and cash equivalents | |||
Cash and cash equivalents at beginning of the year | |||
Cash and cash equivalents at end of the year | 10 | ||
Being: | |||
Cash and cash equivalents | |||
Foreign | Share-based | ||||||
Share capital | Share premium | Retained | Capital | currency | payment | Total equity | |
earnings | contribution | translation | reserve | ||||
reserve | |||||||
GBP | GBP | GBP | GBP | GBP | GBP | ||
Balance as at 1 January 2022 | ( | ( | |||||
Loss for the year | ( | ( | |||||
Equity settled share-based payment | |||||||
Balance as at 31 December 2022 | ( | ( | |||||
Balance as at 1 January 2023 | ( | ( | |||||
Loss for the year | ( | ( | |||||
Total comprehensive income | ( | ( | |||||
Capital reorganisation and deemed distribution | ( | ( | ( | ( | |||
Issued subsequent to the Transaction | |||||||
Warrants exercised subsequent to the transaction | |||||||
Subsidiary shareholding in Company | ( | ( | ( | ||||
Equity settled share-based payments | |||||||
Balance as at 31 December 2023 | ( | ( |